Brain Tumor Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, and Others), By Indication (Pituitary, Meningioma, Glioma, and Others), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 10.2% from 2023-2030

Unit

Value (USD Billion)

Segmentation

By Therapy, Indication, Distribution Channel, and Region

By Therapy

• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Others

By Indication

• Pituitary
• Meningioma
• Glioma
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail & Online Pharmacy

By Region

• North America (By Therapy, By Indication, By Distribution Channel, and By Country)
• U.S. (By Indication)
• Canada (By Indication)
• Europe (By Therapy, By Indication, By Distribution Channel, and By Country)
• U.K. (By Indication)
• Germany (By Indication)
• France (By Indication)
• Italy (By Indication)
• Spain (By Indication)
• Rest of Europe (By Indication)

• Asia Pacific (By Therapy, By Indication, By Distribution Channel, and By Country)

• China (By Indication)
• Japan (By Indication)
• India (By Indication)
• Australia (By Indication)
• Southeast Asia (By Indication)
• Rest of Asia Pacific (By Indication)
• Latin America (By Therapy, By Indication, By Distribution Channel, and By Country)
• Brazil (By Indication)
• Mexico (By Indication)
• Rest of Latin America (By Indication)
• Middle East & Africa (By Therapy, By Indication, By Distribution Channel, and By Country)

• GCC (By Indication)
• South Africa (By Indication)
• Rest of Middle East & Africa (By Indication)